South Korea · Delayed Price · Currency is KRW Biodyne Statistics
Total Valuation
Biodyne has a market cap or net worth of KRW 204.57 billion. The enterprise value is 189.82 billion.
| Market Cap | 204.57B |
| Enterprise Value | 189.82B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Biodyne has 29.48 million shares outstanding.
| Current Share Class | 29.48M |
| Shares Outstanding | 29.48M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +10.73% |
| Owned by Insiders (%) | 42.62% |
| Owned by Institutions (%) | 0.44% |
| Float | 16.91M |
Valuation Ratios
The trailing PE ratio is 161.64 and the forward PE ratio is 46.81.
| PE Ratio | 161.64 |
| Forward PE | 46.81 |
| PS Ratio | 35.43 |
| PB Ratio | 4.65 |
| P/TBV Ratio | 5.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 168.97 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 155.24 |
| EV / Sales | 32.87 |
| EV / EBITDA | 140.69 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 45.95, with a Debt / Equity ratio of 0.00.
| Current Ratio | 45.95 |
| Quick Ratio | 44.51 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | -0.00 |
| Interest Coverage | 494.45 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 0.26% |
| Return on Capital Employed (ROCE) | 0.18% |
| Weighted Average Cost of Capital (WACC) | 10.20% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -22.28M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.71% in the last 52 weeks. The beta is 1.08, so Biodyne's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | -49.71% |
| 50-Day Moving Average | 8,246.80 |
| 200-Day Moving Average | 11,467.65 |
| Relative Strength Index (RSI) | 32.14 |
| Average Volume (20 Days) | 34,467 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biodyne had revenue of KRW 5.77 billion and earned 1.22 billion in profits. Earnings per share was 42.94.
| Revenue | 5.77B |
| Gross Profit | 3.52B |
| Operating Income | 77.13M |
| Pretax Income | 1.20B |
| Net Income | 1.22B |
| EBITDA | 1.35B |
| EBIT | 77.13M |
| Earnings Per Share (EPS) | 42.94 |
Balance Sheet
The company has 14.75 billion in cash and 6.33 million in debt, with a net cash position of 14.75 billion or 500.29 per share.
| Cash & Cash Equivalents | 14.75B |
| Total Debt | 6.33M |
| Net Cash | 14.75B |
| Net Cash Per Share | 500.29 |
| Equity (Book Value) | 44.00B |
| Book Value Per Share | 1,498.36 |
| Working Capital | 17.04B |
Cash Flow
In the last 12 months, operating cash flow was 1.21 billion and capital expenditures -4.08 billion, giving a free cash flow of -2.87 billion.
| Operating Cash Flow | 1.21B |
| Capital Expenditures | -4.08B |
| Depreciation & Amortization | 1.27B |
| Net Borrowing | -9.44M |
| Free Cash Flow | -2.87B |
| FCF Per Share | -97.32 |
Margins
Gross margin is 60.97%, with operating and profit margins of 1.34% and 21.18%.
| Gross Margin | 60.97% |
| Operating Margin | 1.34% |
| Pretax Margin | 20.79% |
| Profit Margin | 21.18% |
| EBITDA Margin | 23.37% |
| EBIT Margin | 1.34% |
| FCF Margin | n/a |
Dividends & Yields
Biodyne does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 0.60% |
| FCF Yield | -1.40% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on February 28, 2024. It was a forward split with a ratio of 5.
| Last Split Date | Feb 28, 2024 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |